Pharmafile Logo
Pharmafocus logo
Advanced Search
Pfizer's website

Pfizer launches ‘Campaign Against Migraine’ website

June 18, 2012
Medical Communications Botox, Pfizer, Relpax, digital, migraine

Pfizer has launched a new website called ‘Campaign Against Migraine’ to help migraine sufferers in the US learn more about …

News

New director appointments to the NHS Commissioning Board

June 18, 2012
Medical Communications, Sales and Marketing Lansley, NHS, reforms

Lord Adebowale, Margaret Casely-Hayford, Dame Moira Gibb and Naguib Kheraj have been confirmed as four new non-executive directors of the …

Appointment
Zytiga image

Janssen looks to broaden Zytiga licence

June 18, 2012
Sales and Marketing Cancer, Janssen, NICE, Provenge, Zytiga, prostate

Janssen is looking to broaden the licence for its prostate cancer pill Zytiga. Zytiga currently has a US and European …

News
redfern_celgene

New director of market access at Celgene UK and Ireland

June 18, 2012
Business Services, Medical Communications, Sales and Marketing Celgene, Nicola Redfern, oncology

Celgene has announced the appointment of Nicola Redfern as director of market access, Celgene UK and Ireland. Redfern brings a …

Appointment

Lundbeck to slash 600 jobs in Europe

June 15, 2012
Sales and Marketing Cipralex, Europe, Lundbeck, austerity, cuts

Lundbeck will cut 600 jobs from its operations in Europe as its Cipralex parent expiry continues to erode revenue. The …

News
NICE app

NICE launches new BNF prescribing app

June 15, 2012
Medical Communications, Sales and Marketing BNF, NICE, app, digital, pharma

NICE has launched a new app that allows users to search all medicines listed in the British National Formulary. The …

News
Merck image

Merck’s sleep aid drug meets goals

June 15, 2012
Research and Development, Sales and Marketing FDA, Merck, insomnia, sleep disorder, suvorexant

Merck’s novel insomnia drug suvorexant has improved patients’ ability to fall asleep, according to new data from two Phase III …

News
Zelboraf image

Roche’s Zelboraf rejected by NICE

June 15, 2012
Sales and Marketing Cancer, Dillon, NICE, Roche, Zelboraf, melanoma

NICE is not recommending Roche’s targeted melanoma pill Zelboraf because of its high cost and uncertainties over its survival benefit. …

News
Novo Nordisk image

BMJ: diabetes post-marketing studies used to boost sales

June 14, 2012
Sales and Marketing BMJ, Edwin Gale, Novo Nordisk, post-marketing

The use of post-marketing studies for diabetes is being used to sell more medicines rather than for science, according to …

News
Deepak Khanna

UK drug pricing: ABPI wants evolution, not revolution

June 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

Feature
screen_shot_2012-06-14_at_14

Conor Griffin joins Tudor Reilly’s senior team

June 14, 2012
Business Services, Medical Communications, Sales and Marketing Conor Griffin, Tudor Reilly, healthcare comms

Healthcare specialist Tudor Reilly has strengthened its senior management with the appointment of Conor Griffin as director.  He joins the …

Appointment

New chair of Health Research Authority confirmed by DH

June 14, 2012
Medical Communications, Research and Development, Sales and Marketing

Professor Jonathan Montgomery will head up the Health Research Authority, the new organisation that will protect and promote the interests …

Appointment
Social media

ABPI: we don’t have the answers for digital yet

June 14, 2012
Medical Communications, Sales and Marketing ABPI, Bayer, Deepak Khanna, Shire, digital, online

Pharma’s use of digital media is posing questions that can’t yet be answered, says the new ABPI president Deepak Khanna. …

News

AstraZeneca swings axe at Swedish plant

June 14, 2012
Sales and Marketing AstraZeneca, Brennan, Sweden, Södertälje, cuts

AstraZeneca will be cutting 400 jobs from its facility in Sweden, the company has confirmed.  Speaking to the TT news …

News
sanofi website

Positive data for Sanofi’s diabetes drug

June 13, 2012
Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …

News

GSK pays £146 million for eczema drug

June 13, 2012
Sales and Marketing Basilea, GSK, Stiefel, Toctino

GlaxoSmithKline has paid £146 million for Basilea Pharmaceutica’s dermatology drug Toctino. Toctino (alitretinoin) is approved for the treatment of adults …

News

New appointments at Events 4 Healthcare

June 13, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing Events 4 Healthcare, NHS

Events 4 Healthcare has announced two new appointments to enhance the team on the back of a number of new …

Appointment

AmerisourceBergen merges pharma packing units

June 12, 2012
Manufacturing and Production AmericsourceBergen, Anderson Packaging, Taylor

Brecon Pharmaceuticals of the UK has officially joined forces with US firm Anderson Packaging to form a new pharma-focused packaging …

News
screen_shot_2012-06-12_at_15

Ark Therapeutics appoints new head of business development

June 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ark Therapeutics, Bachem, Eden Biodesign, Watson

Ark Therapeutics has announced that Kassim Kolia has been appointed as head of business development.  In this role, Kolia will …

Appointment
bob_harrell

Appature appoints new vice president Bob Harrell

June 12, 2012
Business Services, Medical Communications, Sales and Marketing Appature, Harrell, Med Comms, cloud-based, saas

Cloud-based software company Appature has appointed Bob Harrell as the company’s new vice president of marketing, healthcare. Appature, a software-as-a-service …

Appointment
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026